Influenza Vaccination Coverage in Children: How Has COVID-19 Influenced It? A Review of Five Seasons (2018-2023) in Central Catalonia, Spain.
COVID-19
children
influenza vaccine
vaccination coverage
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
18 Aug 2024
18 Aug 2024
Historique:
received:
12
07
2024
revised:
15
08
2024
accepted:
16
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Influenza vaccination is the main method of preventing influenza. Vaccination is recommended for certain individuals with diseases that could cause complications in the case of flu infection. The objective of this retrospective observational study was to examine influenza vaccination coverage in patients with risk factors, to describe the characteristics of those vaccinated and to study the influence of COVID-19. The study population was children under 14 years old with risk factors between 2018/19 and 2022/23 in Central Catalonia, sourced through the electronic database of the Catalan Institute of Health. The association of influenza vaccination data with sociodemographic data and risk factors was performed by bivariate and multivariate analysis. A total of 13,137 children were studied. Of those, 4623 had received the influenza vaccine in at least one season. The average influenza vaccination rate was 28.8%. The statistically significant factors associated with vaccination were age and having certain risk factors: asthma, diabetes, haemoglobinopathies and clotting disorders. In all seasons, the immigrant population was vaccinated more than the native population
Identifiants
pubmed: 39204048
pii: vaccines12080925
doi: 10.3390/vaccines12080925
pmc: PMC11358914
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Pediatrics. 2022 Oct 1;150(4):
pubmed: 36065750
Vaccines (Basel). 2022 Dec 09;10(12):
pubmed: 36560519
J Infect. 2007 May;54(5):483-9
pubmed: 17046065
Vaccine. 2016 Jun 14;34(28):3298-302
pubmed: 27155498
An Pediatr (Barc). 2023 Jun 24;:
pubmed: 38620096
Ital J Pediatr. 2022 May 16;48(1):77
pubmed: 35578296
J Glob Health. 2020 Dec;10(2):021102
pubmed: 33312512
MMWR Morb Mortal Wkly Rep. 2021 Nov 12;70(45):1575-1578
pubmed: 34758010
Enferm Infecc Microbiol Clin. 2015 Jan;33(1):22-6
pubmed: 24556268
Vaccines (Basel). 2022 Sep 26;10(10):
pubmed: 36298475
PLoS One. 2023 Feb 15;18(2):e0281812
pubmed: 36791134
Hum Vaccin Immunother. 2014;10(2):449-55
pubmed: 24280728
Vaccine. 2021 Jul 13;39(31):4291-4295
pubmed: 34172330
PLOS Glob Public Health. 2022 Oct 21;2(10):e0000628
pubmed: 36962643
Pediatrics. 2013 Feb;131(2):207-16
pubmed: 23296444
Public Health. 2023 Dec;225:291-298
pubmed: 37956641
An Pediatr (Engl Ed). 2019 Feb;90(2):86-93
pubmed: 30055938
Nat Rev Dis Primers. 2018 Jun 28;4(1):3
pubmed: 29955068
Public Health. 2023 May;218:68-74
pubmed: 36972643
Int J Environ Res Public Health. 2021 Jan 22;18(3):
pubmed: 33499422
Epidemiol Infect. 2002 Dec;129(3):525-33
pubmed: 12558335
An Pediatr (Engl Ed). 2020 Sep;93(3):183-193
pubmed: 32178966
Vaccine. 2022 Oct 19;40(44):6391-6396
pubmed: 36182616
Vaccine. 2010 Aug 31;28(38):6203-9
pubmed: 20650340
Hum Vaccin Immunother. 2022 Nov 30;18(5):2075211
pubmed: 35621293
Vaccine. 2023 Jul 12;41(31):4554-4560
pubmed: 37328348
Hum Vaccin Immunother. 2018 Mar 4;14(3):693-698
pubmed: 28922083
J Infect. 2008 Dec;57(6):472-80
pubmed: 19010553
Euro Surveill. 2012 Jan 26;17(4):
pubmed: 22297139
Influenza Other Respir Viruses. 2018 Jan;12(1):113-121
pubmed: 29243369
Vacunas. 2020 Jul-Dec;21(2):129-135
pubmed: 32837461
Public Health. 2009 Jul;123(7):465-9
pubmed: 19535118
Hum Vaccin Immunother. 2024 Dec 31;20(1):2287294
pubmed: 38299510
An Pediatr (Barc). 2006 Oct;65(4):331-6
pubmed: 17020728